Sex differences in antidepressant response in recent antidepressant clinical trials

Journal of Clinical Psychopharmacology

Volumn 25, Issue 4, 2005, Pages 318-324

  Khan, Arif ^a,b,f   Brodhead, Amy E ^a   Schwartz, Kelly A ^a   Kolts, Russell L ^c   Brown, Walter A ^d,e  

^a Northwest Clinical Research Center   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c EASTERN WASHINGTON UNIVERSITY   (United States)

^d BROWN UNIVERSITY   (United States)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; IMIPRAMINE; NEFAZODONE; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; META ANALYSIS; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CLINICAL TRIALS; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NOREPINEPHRINE; SEROTONIN UPTAKE INHIBITORS; SEX FACTORS; TREATMENT OUTCOME;

EID: 23044451973     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000168879.03169.ce     Document Type: Article

References (27)

1. Hales RE, Yudofsky SC, Talbott JA. Textbook of Psychiatry. 3rd ed. Washington DC: American Psychiatric Press; 1999.
2. Prange AJ Jr, Wilson IC, Rabon AM, et al. Enhancement of imipramine antidepressant activity by thyroid hormone. Am J Psychiatry. 1969; 126(4):457-469.
3. Prange AJ Jr, Wilson IC, Knox A, et al. Enhancement of imipramine by thyroid stimulating hormone: clinical and theoretical implications. Am J Psychiatry. 1970;127(2):191-199.
4. Altshuler LL, Bauer M, Frye MA, et al. Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature. Am J Psychiatry. 2001;158(10):1617-1622.
5. Nishizawa S, Benkelfat C, Young SN, et al. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci USA. 1997;94(10):5308-5313.
6. Agren H, Mefford IN, Rudorfer MV, et al. Interacting neurotransmitter systems. A non-experimental approach to the 5HIAA-HVA correlation in human CSF. J Psychiatr Res. 1986;20(3):175-193.
7. Young SN, Gauthier S, Anderson GM, et al. Tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human cerebrospinal fluid: interrelationships and the influence of age, sex, epilepsy and anticonvulsant drugs. J Neurol Neurosurg Psychiatry. 1980;43(5): 438-445.
8. Bell C, Abrams J, Nutt D. Tryptophan depletion and its implications for psychiatry. Br J Psychiatry. 2001;178:399-405.
9. Bano S, Akhter S, Afridi MI. Gender based response to fluoxetine hydrochloride medication in endogeneous depression. J Coll Physicians Surg Pak. 2004;14(3):161-165.
10. Neumeister A. Tryptophan depletion, serotonin, and depression: where do we stand? Psychopharmacol Bull 2003;37(4):99-115.
11. Kornstein SG, Schatzberg AF, Thase ME, et al. Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry. 2000;157:1445-1452.
12. Sagud M, Hotujac LJ, Mihaljevic-Peles A, et al. Gender differences in depression. Coll Antropol. 2002;26(1):149-157.
13. Baca E, Garcia-Garcia M, Porras-Chavarino A. Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders. Prog Neuro-Psychopharmacol Biol Psychiatry. 2004;28(1):57-65.
14. Parker G, Parker K, Austin MP, et al. Gender differences in response to differing antidepressant drug classes: two negative studies. Psychol Med. 2003;33:1473-1477.
15. Quitkin FM, Stewart JW, McGrath PJ, et al. Are there differences between women's and men's antidepressant responses? Am J Psychiatry. 2002;159(11):1848-1854.
16. Hildebrandt MG, Steyerberg EW, Stage KB, et al. Are gender difference important for the clinical effects of antidepressants? Am J Psychiatry. 2003;160(9):1643-1650.
17. Wohlfarth T, Storosum JG, Elferink AJA, et al. Response to tricyclic antidepressants: independent of gender? Am J Psychiatry. 2004;161(2): 370-372.
18. Thiels C, Linden M, Grieger F, et al. Gender differences in routine treatment of depressed outpatients with the selective serotonin reuptake inhibitor sertraline. Int Clin Psychopharmacol. 2005;20(1):1-7.
19. Yonkers KA, Brawman-Mintzer O. The pharmacologie treatment of depression: is gender a critical factor? J Clin Psychiatry. 2002;63(7): 610-615.
20. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
21. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389.
22. Khan A, Brodhead AE, Kolts RL. Relative sensitivity of the Montgomery-Asberg Depression Rating Scale, the Hamilton Depression rating scale, and the Clinical Global Impressions rating scale in antidepressant clinical trials: a replication analysis. Int Clin Psychopharmacol. 2004; 19(3):157-160.
23. Khan A, Khan SR, Shankles EB, et al. Relative sensitivity of the Montgomery-Asberg Depression Rating Scale, the Hamilton Depression rating scale, and the Clinical Global Impressions rating scale in antidepressant clinical trials. Int Clin Psychopharmacol. 2002;17:281-285.
24. Khan A, Brodhead AE, Kolts RL, et al. Severity of depressive symp-toms and response to antidepressants and placebo in antidepressant clinical trials. J Psychiatric Res. 2005;39:145-150.
25. Khan A, Leventhal RM, Khan S, et al. Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration Database. J Clin Psychopharmacol. 2002;22(1): 40-45.
26. Bies RR, Bigos KL, Pollock BG. Gender differences in the pharmacokinetics and pharmacodynamics of antidepressants. J Gend Specif Med. 2003;6(3):12-20.
27. Zimmerman M, Mattia JI, Posternak MA. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice. Am J Psychiatry. 2002;159(3):469-473.